文献速递慢阻肺

振荡性正压呼气装置辅助慢阻肺排痰的系统评价与荟萃分析

Use of oscillatory positive expiratory pressure (OPEP) devices to augment sputum clearance in COPD: a systematic review and meta-analysis.
PubMed 文献 · Thorax · 2020-08-11

该系统评价与荟萃分析检索截至2020年3月的文献,纳入8项评估OPEP装置在COPD中疗效的临床试验。汇总分析显示低级别证据表明OPEP装置与COPD症状和急性加重减少(OR 0.37,95%CI 0.19-0.72)及运动能力改善相关,但研究多为短期且偏倚风险高,需更高质量研究验证长期疗效。

要点

  • OPEP装置可能与COPD症状和急性加重减少相关(OR 0.37)。
  • OPEP装置可能改善6分钟步行距离(平均差49.8米)。
  • 证据等级低,研究多为短期且高偏倚风险。

核心结论

  • OPEP装置对COPD患者可能有积极影响,但效应量的置信度低。
  • 需要进一步高质量研究探讨长期疗效及识别更可能受益的患者表型。

研究设计与样本

  • 系统评价与荟萃分析,检索PubMed、CINAHL、Medline(Ovid)、Cochrane和Embase截至2020年3月。
  • 纳入8项临床试验(6项随机对照试验和2项交叉研究),评估OPEP装置在COPD患者中的疗效。

主要发现

  • 汇总分析显示低级别证据表明OPEP装置使用与COPD症状和急性加重减少相关(OR 0.37,95%CI 0.19至0.72)。
  • OPEP装置使用与运动能力改善相关,6分钟步行距离平均差(95%CI)为49.8米(14.2米至85.5米),p=0.009。
  • 平均接受率、完成率和脱落率分别为82%、91%和8%。

临床怎么用

  • OPEP装置可考虑用于COPD患者辅助排痰,但需认识到证据确定性低。
  • 临床决策时应结合患者具体情况,并关注长期疗效的不确定性。

局限性

  • 纳入研究多为短期,大多数具有高偏倚风险。
  • 证据等级低,效应量的置信度有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Oscillating positive expiratory pressure (OPEP) devices are intended to facilitate sputum clearance in chronic obstructive pulmonary disease (COPD), but there is uncertainty as to their place in treatment pathways. We aimed to review the existing literature to establish the evidence base for their use. METHODS: A systematic search of records up to March 2020 was performed on PubMed, CINAHL, Medline (Ovid), Cochrane and Embase to retrieve clinical trials that evaluated the efficacy of OPEP devices in patients with COPD. Two independent reviewers retrieved the titles, abstracts and full texts, and completed the data extraction. RESULTS: Following full-text review of 77 articles, eight (six randomised control trials and 2 cross-over studies) were eligible for inclusion. Pooled analysis showed low-grade evidence that the use of OPEP devices was associated with decreased COPD symptoms and exacerbations (OR 0.37, 95% CI 0.19 to 0.72), and enhanced exercise capacity; 6 min walk distance (mean difference (95% CI), 49.8 m (14.2 m to 85.5 m); p=0.009]). However, studies were mostly short term with the majority having a high risk of bias. The average acceptance, completion and drop-out rates were 82%, 91% and 8%, respectively. CONCLUSION: The use of OPEP devices can have a positive impact in COPD, but confidence in effect sizes is low and there is a need for further, higher quality studies to examine their long-term efficacy in COPD as well as to identify specific patient phenotypes that are more likely to respond. PROSPERO REGISTRATION NUMBER: CRD 42016041835.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Alghamdi SM, Barker RE, Alsulayyim ASS, et al. Use of oscillatory positive expiratory pressure (OPEP) devices to augment sputum clearance in COPD: a systematic review and meta-analysis. Thorax. 2020. PMID: 32788259. doi:10.1136/thoraxjnl-2019-214360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。